News | Artificial Intelligence | August 10, 2023

Blackford and AI4MedImaging Announce Partnership to enhance AI solutions offering for Cardiac MRI

Partnership makes AI4MedImaging’s AI4CMR solution available on the Blackford Platform 

Partnership makes AI4MedImaging’s AI4CMR solution available on the Blackford Platform

August 10, 2023 — Blackford, the pioneering strategic imaging AI platform and solutions provider, and AI4MedImaging, a cardiac MRI solution provider announce a partnership to make the AI4CMR solution available on the Blackford Platform. AI4CMR will enable Blackford customers to automatically segment and quantify cardiac MRI measurements. 

"Blackford’s mission is to deliver AI that provides value to healthcare providers to increase efficiency and improves patient outcomes,” said Blackford CEO Ben Panter. “We are excited to increase our cardiac MRI solution offering on the Blackford Platform with AI4MedImaging.” 

AI4CMR uses artificial intelligence to calculate, quantify, and analyse the left and right ventricle within 2 minutes, and produces a structured report to be extracted to any reporting system. It also provides a triage functionality for wall motion detection (this functionality is CE marked and FDA-pending). 

“AI4MedImaging is thrilled to partner with Blackford and contribute to the democratization of Cardiac Magnetic Resonance. With AI4CMR, the first cardiac AI to receive CE and FDA approval, analysis is fast, accurate, made-easy and available at any location due to the web-based cloud technology used,” said AI4MedImaging’s CEO and MD Vítor Pereira. 

For more information: www.blackfordanalysis.com


Related Content

News | FDA

November 20, 2023 — A groundbreaking advancement in the treatment of patients with uncontrolled hypertension (HTN) has ...

Home November 20, 2023
Home
News | FDA

November 17, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home November 17, 2023
Home
News | FDA

November 8, 2023 — Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. has announced that the U ...

Home November 08, 2023
Home
News | FDA

November 7, 2023 — The U.S. Food and Drug Administration (FDA) announced that Teleflex, and its subsidiary Arrow ...

Home November 07, 2023
Home
News | FDA

October 4, 2023 — Anumana, Inc., a leading AI-driven health technology and nference portfolio company working in ...

Home October 04, 2023
Home
News | FDA

October 3, 2023 — EnCompass Technologies, Inc., a privately held medical device company focused on protecting patients ...

Home October 03, 2023
Home
News | FDA

September 27, 2023 — Boston Scientific announced the FDA clearance of the AVVIGOTM+ Multi-Modality Guidance System, a ...

Home September 27, 2023
Home
News | FDA

August 18, 2023 — The U.S. Food and Drug Administration (FDA) announced that Abiomed is recalling the labeling for ...

Home August 18, 2023
Home
News | FDA

August 15, 2023 — Argus Cognitive, Inc., a digital health company that develops software medical devices, announced that ...

Home August 15, 2023
Home
Subscribe Now